Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,028 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma.
Uramoto H, Shimokawa H, Hanagiri T, Kuwano M, Ono M. Uramoto H, et al. Among authors: shimokawa h. Lung Cancer. 2011 Sep;73(3):361-5. doi: 10.1016/j.lungcan.2011.01.008. Epub 2011 Feb 18. Lung Cancer. 2011. PMID: 21315472
Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis.
Chundong G, Uramoto H, Onitsuka T, Shimokawa H, Iwanami T, Nakagawa M, Oyama T, Tanaka F. Chundong G, et al. Among authors: shimokawa h. Anticancer Res. 2011 Apr;31(4):1141-5. Anticancer Res. 2011. PMID: 21508357
Pleural lavage cytology immediately after thoracotomy in patients with completely resected non-small cell lung cancer.
Hanagiri T, Takenaka M, Oka S, Baba T, Shigematsu Y, Nagata Y, Shimokawa H, Yasuda M, Uramoto H, Takenoyama M, Yasumoto K. Hanagiri T, et al. Among authors: shimokawa h. Int Surg. 2011 Apr-Jun;96(2):171-5. doi: 10.9738/1395.1. Int Surg. 2011. PMID: 22026312
Epidermal growth factor receptor-GEP100-Arf6 axis affects the prognosis of lung adenocarcinoma.
Oka S, Uramoto H, Shimokawa H, Yamada S, Tanaka F. Oka S, et al. Among authors: shimokawa h. Oncology. 2014;86(5-6):263-70. doi: 10.1159/000360089. Epub 2014 Jun 4. Oncology. 2014. PMID: 24902879
Discrepancy between the Clinical Image and Pathological Findings of Non-Small Cell Lung Cancer Harboring an Epidermal Growth Factor Receptor Gene Mutation That Was Surgically Resected after Gefitinib Treatment.
Chikaishi Y, Uramoto H, Oka S, Nagata S, Shimokawa H, So T, Yamada S, Hanagiri T, Mukae H, Tanaka F. Chikaishi Y, et al. Among authors: shimokawa h. Case Rep Oncol. 2014 Feb 20;7(1):126-31. doi: 10.1159/000360154. eCollection 2014 Jan. Case Rep Oncol. 2014. PMID: 24707260 Free PMC article.
Factors predicting the surgical outcome in patients with T3/4 lung cancer.
Uramoto H, Shimokawa H, Hanagiri T, Ichiki Y, Tanaka F. Uramoto H, et al. Among authors: shimokawa h. Surg Today. 2014 Dec;44(12):2249-54. doi: 10.1007/s00595-014-0861-0. Epub 2014 Feb 16. Surg Today. 2014. PMID: 24532177
Postoperative bleeding after surgery in patients with lung cancer.
Uramoto H, Shimokawa H, Tanaka F. Uramoto H, et al. Among authors: shimokawa h. Anticancer Res. 2014 Feb;34(2):981-4. Anticancer Res. 2014. PMID: 24511043
Clinical significance of epithelial-mesenchymal transition-associated markers in malignant pleural mesothelioma.
Iwanami T, Uramoto H, Nakagawa M, Shimokawa H, Yamada S, Kohno K, Tanaka F. Iwanami T, et al. Among authors: shimokawa h. Oncology. 2014;86(2):109-16. doi: 10.1159/000356874. Epub 2014 Jan 21. Oncology. 2014. PMID: 24457449
Serum level of osteopontin as a prognostic factor in patients who underwent surgical resection for non-small-cell lung cancer.
Takenaka M, Hanagiri T, Shinohara S, Yasuda M, Chikaishi Y, Oka S, Shimokawa H, Nagata Y, Nakagawa M, Uramoto H, So T, Yamada S, Tanaka F. Takenaka M, et al. Among authors: shimokawa h. Clin Lung Cancer. 2013 May;14(3):288-94. doi: 10.1016/j.cllc.2012.09.005. Epub 2012 Nov 1. Clin Lung Cancer. 2013. PMID: 23122494
Results of surgical resection for patients with thymoma according to World Health Organization histology and Masaoka staging.
Shinohara S, Hanagiri T, So T, Yasuda M, Takenaka M, Nagata Y, Shimokawa H, Nakagawa M, Uramoto H, So T, Tanaka F. Shinohara S, et al. Among authors: shimokawa h. Asian J Surg. 2012 Oct;35(4):144-8. doi: 10.1016/j.asjsur.2012.08.005. Epub 2012 Oct 2. Asian J Surg. 2012. PMID: 23063086
1,028 results
Jump to page
Feedback